« Previous
Next »
European Journal of Cancer
Volume 42, Issue 15
, Pages
2472-2479
, October 2006
To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound
To access this article, please choose from the options below
☆ This work was presented at the ASCO and ECCO meetings in 2005.
PII: S0959-8049(06)00607-1
doi: 10.1016/j.ejca.2006.04.023
© 2006 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Cancer
Volume 42, Issue 15
, Pages
2472-2479
, October 2006
